Humana CEO Bruce Broussard said the insurer will not support legislation that makes private health coverage illegal. He’s the second health insurance chief executive to say so, following UnitedHealth Group CEO David Wichmann, with “Medicare for all” proposals a major campaign talking point. (CNBC)

Heron Therapeutics’ non-opioid painkiller was rejected by the Food and Drug Administration. Additional information must be submitted in regards to chemistry, manufacturing and controls for the long-acting painkiller, HTX-011. No additional clinical studies or data analyses was requested. (Endpoints)

GlaxoSmithKline has forecasted that its shingles vaccine sales will be more than $1.3 billion in 2019. Sales in its vaccines unit increased by 20% in Q1. CEO Emma Walmsley said she sees the unit as an area for growth as the drugmaker deals with generic competition for major drugs. (Reuters)

The Centers for Disease Control and Prevention has found that 45% of electric-scooter-related accidents are head injuries, many of which could be prevented if riders wore helmets. Overall, for every 100,000 scooter rides, there are 14.3 injuries. Other findings will be released on Wednesday at the Epidemic Intelligence Service conference in Atlanta. (CNBC)

This week’s episode of The MM&M Podcast features Ogilvy Health’s Andrew Schirmer. The agency executive, along with co-hosts Marc Iskowitz and Larry Dobrow, discuss the WPP shop’s integration with Ogilvy, the state of DTC advertising, his top picks for standout creative, involvement of agencies in public health, and more. (MM&M)